HUTCHMED (China) Limited Sponsored ADR (HCM)
(Delayed Data from NSDQ)
$15.00 USD
-1.31 (-8.03%)
Updated Aug 8, 2025 04:00 PM ET
After-Market: $14.98 -0.02 (-0.13%) 7:58 PM ET
3-Hold of 5 3
C Value C Growth A Momentum B VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
HCM 15.00 -1.31(-8.03%)
Will HCM be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for HCM based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for HCM
How Much Upside is Left in HUTCHMED (HCM)? Wall Street Analysts Think 73.52%
Wall Street Analysts See a 68.3% Upside in HUTCHMED (HCM): Can the Stock Really Move This High?
HCM: What are Zacks experts saying now?
Zacks Private Portfolio Services
HUTCHMED (HCM) Upgraded to Buy: Here's Why
Wall Street Analysts Believe HUTCHMED (HCM) Could Rally 72.83%: Here's is How to Trade
Other News for HCM
HUTCHMED (China) Limited (HCM) Q2 2025 Earnings Call Transcript
HUTCHMED (China) Ltd (HCM) (H1 2025) Earnings Call Highlights: Navigating Challenges with ...
Half Year 2025 HUTCHMED (China) Ltd Earnings Call Transcript
HUTCHMED reports mixed 1H results; updates FY25 outlook
Hutchmed reports 1H EPS $2.61 vs. 15c last year